Physical Activity Level and Insomnia
Launched by CAIRO UNIVERSITY · May 4, 2024
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study will be designed as a case-control study, conducted on 150 females recruited from El_Nassr hospital in Helwan, Cairo, Egypt and from social media. Patients will be divided into two equal groups: group A(75 patients complain from PD according to WaLIDD score)\& group B(75 patients don't complain from PD according to WaLIDD score). All data and information of each female in this study, including name, age, address, weight, height, and menstrual history, will be recorded in a recording data sheet. WaLIDD score will be used to assess PD symptoms, Insomnia Severity Index will be used ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient ages will be ranged between 18-25 years old.
- • 2. They do not receive any drugs.
- • 3. Being a virgin .
- Exclusion Criteria:
- • 1. Using hormonal contraception (such as oral contraceptives and injections).
- • 2. Taking any medications.
- • 3. History of chronic disease.
- • 4. Having any psychiatric or gynecological problems (such as PCO, amenorrhea, women who suffered from menopause).
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Dalia Mohamed Kamel, PhD
Study Chair
Department of Woman's Health, Faculty of Physical Therapy, Cairo University, Giza, Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported